JPRN-UMIN000002663已完成未知
Efficacy and safety of mitiglinide in diabetic patients on maintenance hemodialysis - Efficacy and safety of mitiglinide
ihon University School of Medicine0 个研究点目标入组 30 人开始时间: 2009年10月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria were infectious disease, thyroid disease, liver impairment, malignant tumors, and treatment by steroids.
研究者
相似试验
进行中（未招募）
1 期
Personalized treatment of type 2 diabetesEUCTR2020-000913-33-SEniversity of gothenburg200
已完成
不适用
JIKEI mitigulinide vs sitagliptin study on glycemic variance using continuous glucose monitoring.JPRN-UMIN000005517Jikei University School of Medicine 3-25-8 Nishishimbashi, Minato-ku, Tokyo 105-8461 Japan20
尚未招募
4 期
Assessment of Empagliflozin effects in coronary artery diseaseIRCT20190412043247N2Zanjan University of Medical Sciences100
尚未招募
4 期
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160
已完成
不适用
Efficacy and safety of repaglinide on glycemic control in diabetic patients with chronic renal failure [Diamond study-2]Diabetic patients with chronic renal failureJPRN-UMIN000009166Diamond study group20